Caris Life Sciences, Inc. (CAI) at a glance

Caris Life Sciences, Inc. (CAI) is a mid-cap Healthcare company. It trades at $24.34, with a P/E of 7.6, a 3.7% profit margin and revenue growth of 78.8%. It does not pay a dividend. Vestovix scores it 65/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Income (40/100).

Price

$24.34

Market cap

$5.08B

P/E ratio

7.6

Dividend yield

None

Beta

n/a

52-week range

$14.19 to $39.19